Endothelin receptors, renal effects and blood pressure

被引:43
作者
Boesen, Erika I. [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA
关键词
CHRONIC KIDNEY-DISEASE; DUCT-SPECIFIC KNOCKOUT; ANGIOTENSIN-II; B RECEPTORS; INDUCED HYPERTENSION; RESISTANT HYPERTENSION; MEDULLARY OSMOLALITY; ARTERIAL STIFFNESS; RACIAL-DIFFERENCES; URINARY-EXCRETION;
D O I
10.1016/j.coph.2014.12.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The endothelin system has emerged as a key player in the renal control of salt and water homeostasis, exerting profound effects on both the renal vasculature and tubular epithelial cells. Recent advances include new actions of endothelins in the glomerulus, an emerging role for the ETA receptor in chronic kidney disease (CKD) progression and in tubular function, and a more detailed understanding of the tubular response to high salt intake. A large body of evidence also implicates dysfunction of the endothelin system in hypertension, particularly salt-sensitive hypertension, although recent data suggests important sex-differences may exist. Finally, clinical trials indicate that antagonists of endothelin receptors hold great promise in treating resistant hypertension and proteinuric renal disease.
引用
收藏
页码:25 / 34
页数:10
相关论文
共 100 条
[1]   Collecting duct-specific knockout of endothelia-1 causes hypertension and sodium retention [J].
Ahn, D ;
Ge, YQ ;
Stricklett, PK ;
Gill, P ;
Taylor, D ;
Hughes, AK ;
Yanagisawa, M ;
Miller, L ;
Nelson, RD ;
Kohan, DE .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (04) :504-511
[2]   Endothelin type A receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure [J].
Alexander, BT ;
Rinewalt, AN ;
Cockrell, KL ;
Massey, MB ;
Bennett, WA ;
Granger, JP .
HYPERTENSION, 2001, 37 (02) :485-489
[3]   Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension [J].
Alexander, BT ;
Cockrell, KL ;
Rinewalt, AN ;
Herrington, JN ;
Granger, JP .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 280 (05) :R1388-R1392
[4]  
Allcock GH, 1999, J AM SOC NEPHROL, V10, P2283
[5]   ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats [J].
Allcock, GH ;
Venema, RC ;
Pollock, DM .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1998, 275 (01) :R245-R252
[6]   Vascular inflammation in absence of blood pressure elevation in transgenic murine model overexpressing endothelin-1 in endothelial cells [J].
Amiri, Farhad ;
Paradis, Pierre ;
Reudelhuber, Timothy L. ;
Schiffrin, Ernesto L. .
JOURNAL OF HYPERTENSION, 2008, 26 (06) :1102-1109
[7]   Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice [J].
Amiri, Farhad ;
Ko, Eun A. ;
Javeshghani, Danesh ;
Reudelhuber, Timothy L. ;
Schiffrin, Ernesto L. .
JOURNAL OF HYPERTENSION, 2010, 28 (06) :1243-1251
[8]   Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD) [J].
Andress, Dennis L. ;
Coll, Blai ;
Pritchett, Yili ;
Brennan, John ;
Molitch, Mark ;
Kohan, Donald E. .
LIFE SCIENCES, 2012, 91 (13-14) :739-742
[9]   Divergent Results Using Clinic and Ambulatory Blood Pressures Report of a Darusentan-Resistant Hypertension Trial [J].
Bakris, George L. ;
Lindholm, Lars H. ;
Black, Henry R. ;
Krum, Henry ;
Linas, Stuart ;
Linseman, Jennifer V. ;
Arterburn, Sarah ;
Sager, Philip ;
Weber, Michael .
HYPERTENSION, 2010, 56 (05) :824-830
[10]   ETA receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension [J].
Barton, M ;
d'Uscio, LV ;
Shaw, S ;
Meyer, P ;
Moreau, P ;
Lüscher, TF .
HYPERTENSION, 1998, 31 (01) :499-504